Annual investigate of EMEND prescription

Study type

• Study topic:
  Human medicinal product
• Study type:
  Non-interventional study
• Scope of the study:
  Other
• If ‘other’, further details on the scope of the study:
  Prescription compliance
• Data collection methods:
  Secondary use of data

Non-interventional study

• Non-interventional study design:
  Cross-sectional

  Other
• Non-interventional study design, other:
  Prescription event monitoring

Study drug and medical condition

• Name of medicine:
  EMEND

Population studied

• Short description of the study population:
  Cancer patients identified from Onco-Analyser/IMS Health database.
• Age groups:
  Adults (18 to < 46 years)

  Adults (46 to < 65 years)

  Adults (65 to < 75 years)

  Adults (75 to < 85 years)

  Adults (85 years and over)
• Special population of interest:
  Other
• Special population of interest, other:
  Cancer patients
• Estimated number of subjects:
  10000

Study design details

• Main study objective:
  The main objective is to check EMEND® prescription compliance in real life
• Outcomes:
  profile of patients, type of cancer, chemotherapy and/or other previous treatments, daily dose, duration of treatment and associated treatments, and to make an annual follow-up of the respect of the conditions of use of EMEND® in comparison with the Therapeutic Information Sheet, over 8 years.
• Data analysis plan:
  This is an observational descriptive cross-sectional study conducted among a panel representative of the doctors in charge of patients with cancer.The results are expressed in patients without extrapolation case:• Description of the population:o Distribution by sexo Distribution by age: 50 years and under, 51-60 years, 61-70 years, 71-80 years, over 80 yearso Distribution by type of cancer• Analysis of Emend prescription conditions:o Distribution by type of treatment (chemotherapy, radiotherapy, surgery)o Distribution according to emetogenic chemotherapy (with cisplatin, high, medium or low emetogenic)• Analysis of EMEND prescription:o Distribution by duration of treatment: 1 day, 2 days, 3 days,> 3 dayso Daily Doseo associated antiemetic treatments